What are Rare Diseases?
While there are many different definitions of what classifies a disease as rare, overall, it is estimated that between 3.5 – 5.9% of the world’s population is affected by a rare disease. There are over 6,000 different kinds of rare diseases that have been identified, the majority being from genetic mutations, with the rest from environmental factors that permanently affect a person’s quality of life, either cognitively, physically, or sometimes both. With a lack of research on many different rare diseases, misdiagnosis is common, especially since many symptoms can vary from patient to patient or be diagnosed with another more common disease. Other challenges, such as accessibility of quality health care and cost, can also bar patients from receiving the diagnosis and subsequent care needed.
Over the past decade, more time and money has been dedicated around the world to the R&D process to better understand rare diseases and the patients they affect, through regulatory incentives for pharmaceutical companies as well as the establishment of agencies like the International Rare Diseases Research Consortium (IRDiRC) and the U.S. National Institutes of Health (NIH). With this new interest, comes new challenges as well, however. Given the small number of patients afflicted with the disease, and the difference in symptoms for many diagnosed with the same disease, it can be difficult to prove the efficacy and safety of the treatment. Additionally, the logistics in reaching patients all over the world that have the disease, especially when misdiagnosis is so common, presents another, equally challenging task.
As our world becomes increasingly more global, accurate translation of the medical documentation, including EHRs, patient informed consent forms, and eCTD/CTD is critical for not only advancing research around the world, but also for helping reach patients of diverse backgrounds afflicted with the disease. With this translation, the possibility of greater global understanding of the rare disease is possible, and can help inspire future research of drug development or health care innovation. That is why here at CSOFT, a leading provider of medical communication solutions, we are available 24 hours a day, 365 days of the year, to ensure our clients and those they serve are receiving the highest-quality translation with a quick turnaround time, all for the best ROI.
Translations for Clinical Trials
Accurate translation for clinical trials is critical in not only ensuring the drug therapy or medical device product’s success globally, but also in reaching patients of diverse backgrounds, including those afflicted with a rare disease. The importance of high-quality translation, that is both time efficient and cost effective, is critical in facilitating patients receiving a life-saving drug therapy or helping them achieve a higher-quality of life.
CSOFT provides the highest-quality translation for medical documentation throughout the R&D process. With our extensive network of subject matter experts, and over 10,000 in-country native linguists, we understand the importance of timely, accurate translations in the life sciences.
Learn more about our clinical trial translations.
We have well-documented and fully traceable information security policies, checklists, and quality records. CSOFT understands the importance of security to our clients and we take nothing for granted when confidentiality is a concern. All our data and security processes comply with our certified ISO standards 13485:2016 and ISO 9001:2015. We are also compliant with ISO 17100 and leverage best practices from ISO 27001.
Learn more about our data security.
In order to effectively globalize research for rare diseases, in-depth knowledge and understanding of local regulatory laws is crucial in the success of the medical device or treatment to market. As markets and the regulatory bodies that oversee them are constantly evolving, staying up-to-date in adapting submission documents is important in saving time and money for life science companies in rare disease research. CSOFT provides customized regulatory consulting services for life science companies looking to expand their services’ or product’s reach with the NMPA, FDA, and EMA.
Learn more about our regulatory consulting services.
High-quality translation is extremely important in the life sciences – inaccurate translation along the way can not only result in wasted time, money, and effort, but also affect patients’ lives. That is why CSOFT is dedicated to ensuring the highest-quality translation and interpretation solutions for every step in the R&D and marketing process for life science companies. In order to do so, we use in-country linguists with a minimum of 7 years of experience, combined with our extensive network of subject matter experts. In addition, we have perfected our localization best practices through linguistic validation, back translation, and terminology management, we have the tools and team to help you reach patients globally, in over 250 languages.
Read more about our quality assurance.